Vitamin Deficiencies and Suppletion in Morbid Obesity

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Vitamin B12 Deficiency
Interventions
DRUG

Hydroxocobalamin

patients are treated for 6 months with hydroxocobalamin. Patients will be treated with once a dose of 2000ug, after that treatment will be continued with a dose of 1000ug per 2 months. At timepoint 0, 2, 4 and 6 months after treatment vitamin B12 will be measured. At timepoint 0 and 6 also homocystein and methylmalonic acid will be measured.

DRUG

FitForMe vitamin B12

patients are treated for 6 months with a daily dose of 1000ug vitamin B12 tablets. At timepoint 0, 2, 4 and 6 months after treatment vitamin B12 will be measured. At timepoint 0 and 6 also homocystein and methylmalonic acid will be measured.

Trial Locations (1)

6800WC

Rijnstate hospital, Arnhem

All Listed Sponsors
lead

Rijnstate Hospital

OTHER

NCT02270749 - Vitamin Deficiencies and Suppletion in Morbid Obesity | Biotech Hunter | Biotech Hunter